SubscribeJust read how in the UK, drugs like Aricpet, Exelon, and Reminyl are no longer available as treatment for mild cases of Alzheimer’s disease.
They are felt to offer too little benefit compared to their expense.
I believe this offers a taste of things to come in the US, as healthcare funds become more and more scarce.
Share This Post:![[Slashdot]](http://www.smart-kit.com/wp-content/uploads/_graphics/slashdot-big.png)
![[Reddit]](http://www.smart-kit.com/wp-content/uploads/_graphics/reddit-big.png)
![[Facebook]](http://www.smart-kit.com/wp-content/uploads/_graphics/facebook-icon.gif){kind=icon}
![[Google]](http://www.smart-kit.com/wp-content/uploads/_graphics/google-bookmark-big.png)
![[StumbleUpon]](http://www.smart-kit.com/wp-content/uploads/_graphics/stumble-big.png)
![[Digg]](http://www.smart-kit.com/wp-content/uploads/_graphics/digg-big.png)
